Jan 26, 2023

Featuring a slide presentation and related discussion from Professor Giuseppe Curigliano, including the following topics:

• Recent data with targeted therapies for patients with HER2-positive metastatic breast cancer (0:00)
• Case: A woman in her early 40s with a new right breast tumor 10 years after adjuvant radiation and...

Jan 26, 2023

Featuring an interview with Professor Giuseppe Curigliano, including the following topics:

• Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future (0:00)
• Optimal treatment of HER2-positive mBC with brain metastases (7:42)
• Screening for and management of T-DXd-related interstitial...

Jan 24, 2023

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer — Faculty Presentation 2: Therapeutic Approaches for Patients with Other Actionable Genomic Alterations — Dr Gregory Riely

CME information and select...

Jan 24, 2023

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer — Faculty Presentation 1: Management of Non-Small Cell Lung Cancer with an EGFR, ALK or ROS1 Abnormality — Dr Zofia Piotrowska

CME information and select...

Jan 24, 2023

Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely, including the following topics:

• Introduction: What Is Targeted Therapy? (0:00)
• EGFR-Activating Mutations (12:23)
• EGFR Exon 20 Insertion Mutations (27:54)
• ALK and ROS1 Rearrangements (31:31)
• HER2 Mutations (36:17)
• NRG1 Fusions (45:39)
• RET Fusions...